COVID-19 Antibodies of Brii Biosciences enters Phase III Trial
Brii Biosciences today announced that its monoclonal antibody combination therapy, BRII-196 and BRII-198, met pre-specified safety ...
Read moreBrii Biosciences today announced that its monoclonal antibody combination therapy, BRII-196 and BRII-198, met pre-specified safety ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.